Find Clinical Trial

Home » Find Clinical Trials » Efficacy and safety of the fixed oral perindopril arginine 5 mg/ amlopidine 5 mg combination compared with perindopril tert-butylamine 4 mg alone in patients not adequately controlled with perindopril tert-butylamine 4 mg monotherapy. A randomised double blind 12 weeks study with up titration after

Efficacy and safety of the fixed oral perindopril arginine 5 mg/ amlopidine 5 mg combination compared with perindopril tert-butylamine 4 mg alone in patients not adequately controlled with perindopril tert-butylamine 4 mg monotherapy. A randomised double blind 12 weeks study with up titration after

← Back

Study Phase	Phase 3

Therapeutic Area	Cardiovascular Diseases

Indication	Hypertension

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	AMLODIPINE, PERINDOPRIL ARGININE, S005985

Active Substance Code	S005985

Protocol Code	CL3-05985-017

Documents and links

Results summary	READ MORE

Scientific publication	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.